IP48-02: Drugs associated the most with Retroperitoneal Fibrosis: assessment of the 1969-2025 Food and Drug Administration (FDA) pharmacovigilance database
Saturday, May 16, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
147B
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!